Brief: Osteopore Partners With Cytomed To Advance MSC-Powered Regeneration
17/10/2024 02:08
Oct 17 (Reuters) - Osteopore Ltd OSX.AX :
* OSTEOPORE PARTNERS WITH CYTOMED TO ADVANCE MSC-POWERED
REGENERATION
* COLLABORATION TO COMBINE CYTOMED'S MESENCHYMAL STEM CELLS
WITH
CO'S BIORESORBABLE SCAFFOLDS
Further company coverage: OSX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Osteopore
See all newsBrief: Osteopore Secures Market Access In Thailand For Full Range Of Orthopaedic Products
Brief: Osteopore Strikes Orthopaedic Deal For 5 Middle East Countries
Brief: Osteopore Achieves Market Access To Saudi Arabia For Craniofacial Products
Brief: Osteopore Launches Clinical Study For Paranasal Augmentation In Patients With Unilateral Cleft Lip
Australia's Osteopore advances on regulatory win in China's Hainan